Vasopressor Initiation in Septic Shock
Vasopressors should be initiated early in septic shock after initial fluid resuscitation of 30 mL/kg crystalloid if mean arterial pressure (MAP) remains below 65 mmHg, without waiting for completion of full fluid resuscitation. 1, 2, 3
Initial Assessment and Fluid Resuscitation
- Begin with crystalloid fluid resuscitation (30 mL/kg) as recommended by the Surviving Sepsis Campaign 1
- Assess for persistent hypotension despite this initial fluid challenge
- Target MAP: ≥65 mmHg for most patients 1, 2
- Consider higher targets (75-85 mmHg) for patients with chronic hypertension 2
Vasopressor Initiation Algorithm
Timing: Start vasopressors early if MAP <65 mmHg persists after initial fluid bolus
First-line agent: Norepinephrine is the first-choice vasopressor 1, 2
Adjunctive vasopressors (if needed):
Monitoring and Ongoing Assessment
- Continuous arterial blood pressure monitoring is recommended 2
- Assess tissue perfusion markers:
- Lactate levels
- Skin perfusion
- Mental status
- Urine output 2
Important Considerations
Fluid status: Ensure adequate volume status before or during vasopressor therapy 2
- Inadequate fluid resuscitation should be avoided
- Continue fluid challenges as long as hemodynamic improvement occurs 1
Central venous access: Administer norepinephrine through a central line when possible to minimize extravasation risk 2
Weaning strategy: After target blood pressure has been maintained for 8 hours without catecholamines, taper vasopressin by 0.005 units/minute every hour as tolerated 4
Pitfalls to Avoid
Delayed initiation: Waiting too long to start vasopressors can prolong hypoperfusion and increase mortality 3
Overreliance on fluids: Complications of fluid over-resuscitation can delay organ recovery, prolong ICU stay, and increase mortality 3
Using dopamine: Avoid dopamine except in highly selected patients with low risk of tachyarrhythmias 1
Ignoring chronic conditions: Failing to adjust MAP targets for patients with chronic hypertension 2
Neglecting monitoring: Not assessing for end-organ perfusion at high vasopressor doses 2